HROW
HarrowยทNASDAQ
--
--(--)
--
--(--)
HROW Profile
Harrow, Inc.
An eyecare pharmaceutical company that developing innovative ophthalmic prescription therapies
1A Burton Hills Blvd., Suite 200, Nashville, TN 37215
--
Harrow, Inc., was incorporated in Delaware in January 2006. The company is a leading eye care pharmaceutical company dedicated to discovering, developing and commercializing innovative ophthalmic pharmaceutical products for the US market. The company owns the commercial rights to a large portfolio of branded ophthalmic medicines sold under the Harrow name and also operates ImprimisRX, a prominent ophthalmology-focused drug compounding business. The company's goal is to make its comprehensive prescription and over-the-counter products accessible and affordable to support eye care professionals across the United States.
